News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Astellas Pharma Inc. (JOBS) Needs to Raise OSI Pharmaceuticals, Inc. (OSIP) Bid by 15%, OrbiMed Says


3/5/2010 7:12:30 AM

Bloomberg -- Astellas Pharma Inc. needs to increase its $3.5 billion hostile takeover bid for OSI Pharmaceuticals Inc. by 15 percent, said OrbiMed Advisors LLC, OSI’s fifth-biggest shareholder.

Read at Bloomberg

Related News

comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES